MedPath

EnviroGold Global Ltd

🇺🇸United States
Ownership
-
Employees
1.2K
Market Cap
-
Website
Introduction

Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.

Nevro's HFX iQ Spinal Cord Stimulation System Receives CE Mark for Personalized Pain Relief

Nevro's HFX iQ spinal cord stimulation (SCS) system, leveraging AI and high-frequency therapy, has secured CE mark in Europe for personalized pain relief.

Nevro's AI-Powered Spinal Cord Stimulation System, HFX iQ with AdaptivAI, Receives FDA Approval

Nevro's HFX iQ with AdaptivAI, an AI-driven spinal cord stimulation system, has gained FDA approval for chronic pain management.

© Copyright 2025. All Rights Reserved by MedPath